Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgotinib dose-finding phase IIb study in rheumatoid arthritis with inadequate response to methotrexate
2012-003635-31Phase 2Completed
- Sponsor
- Galapagos NV
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Filgotinib plus methotrexate with Placebo plus methotrexate (2 arms). Primary endpoint: ACR20 response at Week 12. Started Apr 2013; status: completed.
02
Drugs
filgotinib
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2012-003635-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003635-31.